Rituximab Recruiting Phase 1 / 2 Trials for Plasmablastic Lymphoma / MYC Gene Mutation / B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma / Adult Burkitt Lymphoma / Lymphoma, Large B-Cell, Diffuse (DLBCL) Treatment